Banks - Regional
Compare Stocks
5 / 10Stock Comparison
CATY vs BCAL vs CVBF vs HAFC vs HOPE
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Banks - Regional
CATY vs BCAL vs CVBF vs HAFC vs HOPE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $3.82B | $613M | $2.78B | $908M | $1.60B |
| Revenue (TTM) | $1.38B | $233M | $643M | $445M | $968M |
| Net Income (TTM) | $315M | $63M | $209M | $76M | $59M |
| Gross Margin | 55.1% | 79.4% | 79.9% | 57.5% | 48.6% |
| Operating Margin | 29.4% | 37.8% | 43.8% | 24.3% | 8.3% |
| Forward P/E | 10.4x | 11.4x | 14.2x | 9.6x | 11.7x |
| Total Debt | $209M | $72M | $991M | $280M | $396M |
| Cash & Equiv. | $146M | $52M | $108M | $213M | $560M |
CATY vs BCAL vs CVBF vs HAFC vs HOPE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Cathay General Banc… (CATY) | 100 | 209.6 | +109.6% |
| Southern California… (BCAL) | 100 | 217.9 | +117.9% |
| CVB Financial Corp. (CVBF) | 100 | 105.1 | +5.1% |
| Hanmi Financial Cor… (HAFC) | 100 | 336.4 | +236.4% |
| Hope Bancorp, Inc. (HOPE) | 100 | 131.9 | +31.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CATY vs BCAL vs CVBF vs HAFC vs HOPE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CATY carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 137.4% 10Y total return vs HAFC's 76.5%
- Efficiency ratio 0.3% vs BCAL's 0.4% (lower = leaner)
- +39.5% vs CVBF's +13.1%
- Efficiency ratio 0.3% vs BCAL's 0.4%
BCAL is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.
- Rev growth 26.2%, EPS growth 7.8%
- Lower volatility, beta 0.90, Low D/E 12.4%, current ratio 0.24x
- PEG 0.36 vs CVBF's 4.48
- NIM 4.2% vs HOPE's 2.5%
Among these 5 stocks, CVBF doesn't own a clear edge in any measured category.
HAFC ranks third and is worth considering specifically for income & stability and defensive.
- Dividend streak 5 yrs, beta 0.92, yield 3.6%
- Beta 0.92, yield 3.6%, current ratio 49.21x
- Lower P/E (9.6x vs 14.2x), PEG 0.76 vs 4.48
HOPE is the clearest fit if your priority is dividends.
- 4.4% yield, vs CATY's 2.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 26.2% NII/revenue growth vs HOPE's -3.2% | |
| Value | Lower P/E (9.6x vs 14.2x), PEG 0.76 vs 4.48 | |
| Quality / Margins | Efficiency ratio 0.3% vs BCAL's 0.4% (lower = leaner) | |
| Stability / Safety | Beta 0.90 vs HOPE's 1.10, lower leverage | |
| Dividends | 4.4% yield, vs CATY's 2.4% | |
| Momentum (1Y) | +39.5% vs CVBF's +13.1% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs BCAL's 0.4% |
CATY vs BCAL vs CVBF vs HAFC vs HOPE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CATY vs BCAL vs CVBF vs HAFC vs HOPE — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
BCAL leads in 2 of 6 categories
CVBF leads 1 • CATY leads 0 • HAFC leads 0 • HOPE leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CVBF leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
CATY is the larger business by revenue, generating $1.4B annually — 5.9x BCAL's $233M. CVBF is the more profitable business, keeping 32.5% of every revenue dollar as net income compared to HOPE's 6.0%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.4B | $233M | $643M | $445M | $968M |
| EBITDAEarnings before interest/tax | $431M | $92M | $294M | $110M | $84M |
| Net IncomeAfter-tax profit | $315M | $63M | $209M | $76M | $59M |
| Free Cash FlowCash after capex | $357M | $57M | $217M | $204M | $147M |
| Gross MarginGross profit ÷ Revenue | +55.1% | +79.4% | +79.9% | +57.5% | +48.6% |
| Operating MarginEBIT ÷ Revenue | +29.4% | +37.8% | +43.8% | +24.3% | +8.3% |
| Net MarginNet income ÷ Revenue | +22.8% | +27.1% | +32.5% | +17.1% | +6.0% |
| FCF MarginFCF ÷ Revenue | +26.3% | +24.4% | +33.8% | +45.8% | +15.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +18.8% | -2.0% | +11.1% | +20.7% | +35.0% |
Valuation Metrics
BCAL leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 9.9x trailing earnings, BCAL trades at a 64% valuation discount to HOPE's 27.2x P/E. Adjusting for growth (PEG ratio), BCAL offers better value at 0.31x vs CVBF's 4.25x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $3.8B | $613M | $2.8B | $908M | $1.6B |
| Enterprise ValueMkt cap + debt − cash | $3.9B | $633M | $3.7B | $976M | $1.4B |
| Trailing P/EPrice ÷ TTM EPS | 12.55x | 9.88x | 13.49x | 12.10x | 27.22x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.43x | 11.42x | 14.24x | 9.61x | 11.70x |
| PEG RatioP/E ÷ EPS growth rate | 1.31x | 0.31x | 4.25x | 0.95x | — |
| EV / EBITDAEnterprise value multiple | 9.00x | 7.19x | 13.02x | 8.59x | 17.18x |
| Price / SalesMarket cap ÷ Revenue | 2.76x | 2.63x | 4.33x | 2.04x | 1.66x |
| Price / BookPrice ÷ Book value/share | 1.32x | 1.08x | 1.21x | 1.15x | 0.71x |
| Price / FCFMarket cap ÷ FCF | 10.50x | 10.77x | 12.81x | 4.46x | 10.58x |
Profitability & Efficiency
BCAL leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
BCAL delivers a 11.4% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $3 for HOPE. CATY carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to CVBF's 0.43x. On the Piotroski fundamental quality scale (0–9), HAFC scores 9/9 vs HOPE's 6/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +10.9% | +11.4% | +9.3% | +9.8% | +2.6% |
| ROA (TTM)Return on assets | +1.3% | +1.6% | +1.4% | +1.0% | +0.3% |
| ROICReturn on invested capital | +9.8% | +10.6% | +6.8% | +7.4% | +2.3% |
| ROCEReturn on capital employed | +4.5% | +5.0% | +9.3% | +2.5% | +0.9% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 7 | 6 | 9 | 6 |
| Debt / EquityFinancial leverage | 0.07x | 0.12x | 0.43x | 0.35x | 0.17x |
| Net DebtTotal debt minus cash | $63M | $20M | $883M | $68M | -$164M |
| Cash & Equiv.Liquid assets | $146M | $52M | $108M | $213M | $560M |
| Total DebtShort + long-term debt | $209M | $72M | $991M | $280M | $396M |
| Interest CoverageEBIT ÷ Interest expense | 0.72x | 1.55x | 2.12x | 0.62x | 0.17x |
Total Returns (Dividends Reinvested)
Evenly matched — CATY and HAFC each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HAFC five years ago would be worth $16,465 today (with dividends reinvested), compared to $9,800 for HOPE. Over the past 12 months, CATY leads with a +39.5% total return vs CVBF's +13.1%. The 3-year compound annual growth rate (CAGR) favors HAFC at 33.4% vs BCAL's 13.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +17.9% | +3.3% | +10.9% | +15.2% | +15.3% |
| 1-Year ReturnPast 12 months | +39.5% | +32.9% | +13.1% | +36.9% | +30.4% |
| 3-Year ReturnCumulative with dividends | +116.0% | +47.7% | +94.0% | +137.2% | +80.7% |
| 5-Year ReturnCumulative with dividends | +51.2% | +42.7% | +12.2% | +64.7% | -2.0% |
| 10-Year ReturnCumulative with dividends | +137.4% | +133.6% | +67.6% | +76.5% | +18.8% |
| CAGR (3Y)Annualised 3-year return | +29.3% | +13.9% | +24.7% | +33.4% | +21.8% |
Risk & Volatility
Evenly matched — CATY and BCAL each lead in 1 of 2 comparable metrics.
Risk & Volatility
BCAL is the less volatile stock with a 0.90 beta — it tends to amplify market swings less than HOPE's 1.10 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CATY currently trades 98.3% from its 52-week high vs BCAL's 93.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.04x | 0.90x | 0.94x | 0.92x | 1.10x |
| 52-Week HighHighest price in past year | $58.00 | $20.47 | $21.48 | $31.27 | $13.02 |
| 52-Week LowLowest price in past year | $41.64 | $14.07 | $17.95 | $21.84 | $9.44 |
| % of 52W HighCurrent price vs 52-week peak | +98.3% | +93.2% | +95.5% | +97.2% | +96.2% |
| RSI (14)Momentum oscillator 0–100 | 70.8 | 62.0 | 57.9 | 64.1 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 465K | 189K | 1.6M | 265K | 902K |
Analyst Outlook
Evenly matched — CATY and HOPE each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CATY as "Hold", BCAL as "Buy", CVBF as "Hold", HAFC as "Hold", HOPE as "Hold". Consensus price targets imply 20.7% upside for CVBF (target: $25) vs -17.5% for CATY (target: $47). For income investors, HOPE offers the higher dividend yield at 4.39% vs BCAL's 0.52%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | $47.00 | $22.00 | $24.75 | $35.00 | $14.50 |
| # AnalystsCovering analysts | 13 | 3 | 16 | 11 | 6 |
| Dividend YieldAnnual dividend ÷ price | +2.4% | +0.5% | +4.0% | +3.6% | +4.4% |
| Dividend StreakConsecutive years of raises | 12 | 1 | 4 | 5 | 0 |
| Dividend / ShareAnnual DPS | $1.38 | $0.10 | $0.82 | $1.09 | $0.55 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.7% | +1.0% | +2.9% | +1.0% | 0.0% |
BCAL leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). CVBF leads in 1 (Income & Cash Flow). 3 tied.
CATY vs BCAL vs CVBF vs HAFC vs HOPE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CATY or BCAL or CVBF or HAFC or HOPE a better buy right now?
For growth investors, Southern California Bancorp (BCAL) is the stronger pick with 26.
2% revenue growth year-over-year, versus -3. 2% for Hope Bancorp, Inc. (HOPE). Southern California Bancorp (BCAL) offers the better valuation at 9. 9x trailing P/E (11. 4x forward), making it the more compelling value choice. Analysts rate Southern California Bancorp (BCAL) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CATY or BCAL or CVBF or HAFC or HOPE?
On trailing P/E, Southern California Bancorp (BCAL) is the cheapest at 9.
9x versus Hope Bancorp, Inc. at 27. 2x. On forward P/E, Hanmi Financial Corporation is actually cheaper at 9. 6x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Southern California Bancorp wins at 0. 36x versus CVB Financial Corp. 's 4. 48x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CATY or BCAL or CVBF or HAFC or HOPE?
Over the past 5 years, Hanmi Financial Corporation (HAFC) delivered a total return of +64.
7%, compared to -2. 0% for Hope Bancorp, Inc. (HOPE). Over 10 years, the gap is even starker: CATY returned +137. 4% versus HOPE's +18. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CATY or BCAL or CVBF or HAFC or HOPE?
By beta (market sensitivity over 5 years), Southern California Bancorp (BCAL) is the lower-risk stock at 0.
90β versus Hope Bancorp, Inc. 's 1. 10β — meaning HOPE is approximately 22% more volatile than BCAL relative to the S&P 500. On balance sheet safety, Cathay General Bancorp (CATY) carries a lower debt/equity ratio of 7% versus 43% for CVB Financial Corp. — giving it more financial flexibility in a downturn.
05Which is growing faster — CATY or BCAL or CVBF or HAFC or HOPE?
By revenue growth (latest reported year), Southern California Bancorp (BCAL) is pulling ahead at 26.
2% versus -3. 2% for Hope Bancorp, Inc. (HOPE). On earnings-per-share growth, the picture is similar: Southern California Bancorp grew EPS 777. 3% year-over-year, compared to -43. 9% for Hope Bancorp, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CATY or BCAL or CVBF or HAFC or HOPE?
CVB Financial Corp.
(CVBF) is the more profitable company, earning 32. 5% net margin versus 6. 0% for Hope Bancorp, Inc. — meaning it keeps 32. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CVBF leads at 43. 8% versus 8. 3% for HOPE. At the gross margin level — before operating expenses — CVBF leads at 79. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CATY or BCAL or CVBF or HAFC or HOPE more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Southern California Bancorp (BCAL) is the more undervalued stock at a PEG of 0. 36x versus CVB Financial Corp. 's 4. 48x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Hanmi Financial Corporation (HAFC) trades at 9. 6x forward P/E versus 14. 2x for CVB Financial Corp. — 4. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CVBF: 20. 7% to $24. 75.
08Which pays a better dividend — CATY or BCAL or CVBF or HAFC or HOPE?
All stocks in this comparison pay dividends.
Hope Bancorp, Inc. (HOPE) offers the highest yield at 4. 4%, versus 0. 5% for Southern California Bancorp (BCAL).
09Is CATY or BCAL or CVBF or HAFC or HOPE better for a retirement portfolio?
For long-horizon retirement investors, Southern California Bancorp (BCAL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
90), 0. 5% yield, +133. 6% 10Y return). Both have compounded well over 10 years (BCAL: +133. 6%, HOPE: +18. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CATY and BCAL and CVBF and HAFC and HOPE?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CATY is a small-cap deep-value stock; BCAL is a small-cap high-growth stock; CVBF is a small-cap deep-value stock; HAFC is a small-cap deep-value stock; HOPE is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.